Tim Hackbardt, chief marketing officer at Playa Bowls, highlights that fast-food chains are failing to adapt to the rising use of GLP-1 medications, which significantly alter American eating habits and food spending. With about 23 percent of U.S. households already using GLP-1s and projections that users will account for 35 percent of food and beverage sales by 2030, Hackbardt stresses that the fast-food industry must respond to this lasting shift toward a health-focused consumer mindset.